• Home
  • Stock
  • Medicamen Biotech Fundamental Analysis
  • Medicamen Biotech Fundamental Analysis

Medicamen Biotech fundamental analysis

MEDICAMEQ

HealthcareSmall

402

3.75 (-0.92%)
Last updated on 10 Nov, 2025 | 13:33 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Medicamen Biotech Fundamentals

P/E Ratio

57.93

P/B Ratio

2.18

Div. Yield

0.25

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 57.93, compared to the sector average of 36.99. Its P/B Ratio stands at 2.18, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0.25%, which is than the sector’s 0.56%.

Medicamen Biotech Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Poor

  • Management

    Average

  • On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Moderate, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.